Nearly half of testicular cancer risk comes from inherited genetic faults Almost half of the risk of developing testicular cancer comes from the DNA passed down from our parents. The research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20 percent of risk
Scientists produce cancer drug from rare plant in lab Stanford scientists produced a common cancer drug -- previously only available from an endangered plant -- in a common laboratory plant. This work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective
Pancreatic cancer stem cells could be 'suffocated' by an anti-diabetic drug Pancreatic cancer stem cells are virtually addicted to oxygen-based metabolism, and could be 'suffocated' with a drug already used to treat diabetes.
Errant gene turns cells into mobile cancer factories Scientists have found a key molecular mechanism that underlies deadly behavior in hard-to-treat breast cancer, and have demonstrated how a single master gene, called Sox10, controls if--and to what extent--cells turn into these potentially dangerous factories. This new understanding of Sox10 could help point the way to more efficient therapies for drug-resistant cancers.
Natural compound could reduce breast cancer risk in some women The odds of women being diagnosed with breast cancer increase in postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy; these women also have an increased risk of developing progestin-accelerated breast tumors. Now, researchers have found that luteolin, a natural compound found in herbs such as thyme and parsley as well as vegetables such as celery and broccoli, could reduce the cancer risk for women who have taken hormone replacement therapy.